Kyverna Therapeutics (KYTX) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 Good afternoon and welcome to Jefferies twenty twenty five Global Healthcare Conference. My name is Ashwin Serpaneini with the Jefferies Investment Banking team and it's my great pleasure to introduce Warner Biddle, CEO of Qiverna Therapeutics. Qiverna is focused on liberating patients through the curative potential of cell therapy. Its lead CAR T cell therapy candidate, KYV-one hundred one, is advancing through late stage clinic ...